papaverine
papaverine is a pharmaceutical drug with 10 clinical trials. Currently 2 active trials ongoing. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
2
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial
IV PAPAVERINE Prior to Propess for Labor Induction
Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer
Papaverine and Oxytocin vs Oxytocin Alone in Labor Induction
Papaverine vs Heparin for Peripheral Arterial Catheter Patency in Pediatric Patients
Clinical Trials (10)
Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial
IV PAPAVERINE Prior to Propess for Labor Induction
Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer
Papaverine and Oxytocin vs Oxytocin Alone in Labor Induction
Papaverine vs Heparin for Peripheral Arterial Catheter Patency in Pediatric Patients
Effect of Papaverine on Renal Artery Blood Flow Volume
Prostatic Hyperplasia Treatment and Cancer Prevention
The Effect of Periradial Injection of Papaverine Versus Nitroglycerine on Radial Artery Diameter
Optimal Analgesia in Acute Gastroenteritis
Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10